We are live on !
Find out more
&Partners Portfolio holdings
AUM
$24.4B
Turnover
11.02%
1-Year Est. Return
27.45%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+27.45%
3 Year Est. Return
+78.37%
5 Year Est. Return
+81.51%
10 Year Est. Return
–
AUM
$24.4B
AUM Growth
+$4.13B
(+20%)
Cap. Flow
+$1.89B
Cap. Flow % of AUM
Cap. Flow %
7.77%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
2,595
New
200
Increased
1,495
Reduced
755
Closed
86
Avg Time Held
1.5
years
Top 10 Avg Time Held
2.8
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$71M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$62.1M |
| 3 |
Apple
AAPL
|
+$55.3M |
| 4 |
Microsoft
MSFT
|
+$44.6M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$41.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$14.1M |
| 2 |
First Trust Indxx Aerospace & Defense ETF
MISL
|
+$14M |
| 3 |
Procter & Gamble
PG
|
+$13.9M |
| 4 |
First Trust Energy AlphaDEX Fund
FXN
|
+$13.7M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.56% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.64% |
| 4 | Industrials | 5.77% |
| 5 | Healthcare | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
Virtus Diversified Income & Convertible Fund
ACV
$246M
| $278K | ﹤0.01% |
9,817
+193
| +2% | +$5.19K |
2025 Q4
2 quarters
|
|
2177
Enerpac Tool Group
EPAC
$1.83B
| $278K | ﹤0.01% |
7,757
-2,422
| -24% | -$84.9K |
2024 Q4
6 quarters
|
|
2178
TPG Mortgage Investment Trust
MITT
$173M
| $278K | ﹤0.01% |
35,100
| – | – |
2023 Q4
10 quarters
|
|
2179
Getty Realty Corp
GTY
$1.73B
| $278K | ﹤0.01% |
8,326
+91
| +1% | +$3.02K |
2026 Q1
1 quarter
|
|
2180
Global Net Lease
GNL
$1.67B
| $277K | ﹤0.01% |
31,016
+208
| +0.7% | +$1.94K |
2026 Q1
1 quarter
|
|
2181
CNH Industrial
CNH
$18.5B
| $277K | ﹤0.01% |
24,662
-83
| -0.3% | -$883 |
2025 Q2
4 quarters
|
|
2182
US Physical Therapy
USPH
$1.32B
| $277K | ﹤0.01% |
4,030
-1,668
| -29% | -$113K |
2024 Q4
6 quarters
|
|
2183
iShares MSCI Switzerland ETF
EWL
$2.92B
| $277K | ﹤0.01% |
4,402
+366
| +9% | +$22.5K |
2024 Q2
8 quarters
|
|
2184
Alliance Resource Partners
ARLP
$3.36B
| $276K | ﹤0.01% |
11,523
+1,376
| +14% | +$35K |
2026 Q1
1 quarter
|
|
2185
Thornburg Income Builder Opportunities Trust
TBLD
$651M
| $276K | ﹤0.01% |
12,520
-1,896
| -13% | -$41.7K |
2023 Q4
10 quarters
|
|
2186
Five Below
FIVE
$12.3B
| $276K | ﹤0.01% |
+1,535
| New | +$331K |
2026 Q2
0 quarters
|
|
2187
Sprouts Farmers Market
SFM
$6.18B
| $276K | ﹤0.01% |
3,260
-2,050
| -39% | -$166K |
2025 Q1
5 quarters
|
|
2188
Merit Medical Systems
MMSI
$5.57B
| $275K | ﹤0.01% |
3,969
+744
| +23% | +$49.1K |
2026 Q1
1 quarter
|
|
2189
Franklin Focused Dynamic Growth ETF
FFOG
$354M
| $275K | ﹤0.01% |
+5,351
| New | +$260K |
2026 Q2
0 quarters
|
|
2190
Lemonade
LMND
$3.48B
| $275K | ﹤0.01% |
4,227
+872
| +26% | +$51K |
2025 Q4
2 quarters
|
|
2191
KT
KT
$8.2B
| $275K | ﹤0.01% |
15,931
+325
| +2% | +$6.48K |
2025 Q1
5 quarters
|
|
2192
10x Genomics
TXG
$9.32B
| $275K | ﹤0.01% |
7,172
-6,448
| -47% | -$169K |
2025 Q4
2 quarters
|
|
2193
CAE Inc
CAE
$8.05B
| $275K | ﹤0.01% |
+10,963
| New | +$284K |
2026 Q2
0 quarters
|
|
2194
iShares US Regional Banks ETF
IAT
$641M
| $274K | ﹤0.01% |
4,406
+124
| +3% | +$7.2K |
2025 Q4
2 quarters
|
|
2195
The Ensign Group
ENSG
$10.2B
| $273K | ﹤0.01% |
1,706
-789
| -32% | -$139K |
2025 Q2
4 quarters
|
|
2196
Morgan Stanley Emerging Markets Debt Fund
MSD
$134M
| $273K | ﹤0.01% |
37,377
-1,657
| -4% | -$12.1K |
2025 Q2
4 quarters
|
|
2197
Chemed
CHE
$6.7B
| $272K | ﹤0.01% |
583
-779
| -57% | -$328K |
2024 Q2
8 quarters
|
|
2198
Miller Value Partners Appreciation ETF
MVPA
$74.2M
| $271K | ﹤0.01% |
+8,113
| New | +$268K |
2026 Q2
0 quarters
|
|
2199
Karman Holdings
KRMN
$4.86B
| $271K | ﹤0.01% |
5,429
+617
| +13% | +$39.9K |
2025 Q4
2 quarters
|
|
2200
Fidelity Quality Factor ETF
FQAL
$1.43B
| $271K | ﹤0.01% |
7,661
-4,672
| -38% | -$369K |
2025 Q4
2 quarters
|
|
Similar funds
&Partners's Q2 2026 Portfolio in Review
As of Q2 2026, &Partners held 2,595 positions worth $24.4B, up 20% from $20.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
&Partners deployed $1.89B of net new capital in Q2 2026, opening 200 new positions and adding to 1,495 existing holdings. Its largest new stake was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Palo Alto Networks, an estimated $14.1M trimmed.
- &Partners's largest Q2 2026 buy was iShares International Country Rotation Active ETF: 434,646 shares worth $16M.
- &Partners added most to NVIDIA in Q2 2026, an estimated $71M increase.
- &Partners's biggest Q2 2026 reduction was Palo Alto Networks, cutting an estimated $14.1M.
- &Partners fully exited Avantis Core Fixed Income ETF in Q2 2026, selling an estimated $9.19M.
- &Partners's ten largest holdings make up 21% of its $24.4B portfolio in Q2 2026.
- &Partners opened 200 new positions and closed 86 in Q2 2026.
- &Partners's portfolio value rose 20% quarter-over-quarter to $24.4B.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.